Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 182   

Articles published

AZN 4,578.50 +42.00 (0.93%)
price chart
Is GlaxoSmithKline plc's Opportunity AstraZeneca plc's Threat?
AstraZeneca Pharmaceutical companies are notoriously tricky businesses with massive reward potential; from patent legislation to pricing competitions, the road to medicinal gold is paved with an underlying risk that is beyond the grasp of most of us ...
4 Reasons To Buy AstraZeneca plc
Sometimes, the stock market just doesn't make any sense. Take, for example, AstraZeneca (LSE: AZN) (NYSE: AZN.US). It is currently in the midst of a patent cliff and its bottom line is continuing to fall at a fairly rapid rate.
AstraZeneca Bullish Options Gain on Pfizer Comeback Bets  Businessweek
AstraZeneca plc Earns Neutral Rating from Bryan Garnier & Cie (AZN)  WKRB News
Related articles »  
Your Ultimate FTSE 100 4-Stock Balanced Portfolio: SSE PLC, AstraZeneca plc ...
Sometimes it's tough to strike the right balance between growth and income. Indeed, most investors tend to focus on one or the other, as opposed to creating a portfolio that provides them with a decent income while also having the potential to post ...
Meet The 2 Best Healthcare Stocks Your Money Can Buy: AstraZeneca plc ...
2014 has been a very different experience for investors in AstraZeneca (LSE: AZN) (NYSE: AZN.US) and GlaxoSmithKline (LSE: GSK) (NYSE: GSK.
Related articles »  
3 Stocks To Buy On St Leger Day: AstraZeneca plc, National Grid plc & British ...
After a summer 'dip', the FTSE 100 has shown some signs of life over the last couple of weeks. It's up 3% in the last month alone and, with St. Leger Day upon us, could continue its rise moving forward.
Related articles »  
The Best Reason To Buy AstraZeneca plc
The FTSE's second-biggest pharmaceuticals company AstraZeneca (LSE: AZN) (NYSE: AZN) has been in the news over the past year, with its share price having been boosted by the Pfizer bid attempt, to 4,573p today.
AstraZeneca And Pfizer Can Commence Merger Talks Again  Bidness ETC
Investors Bet AstraZeneca Megamerger Could Live Again  Bloomberg
Related articles »  
A New Pfizer Inc. Bid For AstraZeneca plc?
Firstly, Pfizer needs to seriously boost its pipeline, and even after such a short time in its refocus plan, AstraZeneca is already seeing results.
Pfizer Inc. (NYSE:PFE) Can Raise Its Bid For AstraZeneca plc (ADR) (NYSE:AZN)  WallStreetPR
Pfizer Inc. (NYSE:PFE) Unlikely to Be Successful with Second Bid for ...  BasicsMedia
Related articles »  
AstraZeneca plc Receives "Neutral" Rating from Credit Suisse (AZN)
Credit Suisse reissued their neutral rating on shares of AstraZeneca plc (NYSE:AZN) in a research note released on Tuesday morning.
Take Advantage Of The 'Summer Dip' With The FTSE 100, AstraZeneca plc ...
'Sell in May and don't come back until St. Ledger's day' is a well-known saying in investing circles. Indeed, data from recent decades seems to back it up: the stock market rarely embarks on a sustained summer rally and usually falls between May and ...
Related articles »  
Learning The Hard Way: Imperial Tobacco Group plc And AstraZeneca plc
It is decision time for shareholders of Imperial Tobacco Group (LSE: IMT) and AstraZeneca (LSE: AZN) (NYSE: AZN.US). What do they have in common?